Skip to content

Holding Periods Between Cuts: Stabilization During Benzo Tapers

Person resting peacefully during benzodiazepine taper stabilization period, symbolizing patience and healing between dose ...

A holding period is the stretch of time during which a person stays at a constant dose before making the next reduction in a benzodiazepine taper. Benzodiazepines are prescribed for anxiety disorders, insomnia, seizure disorders, and muscle spasm, and with regular use the central nervous system adapts to them, including changes in the sensitivity and number of gamma-aminobutyric acid (GABA) receptors. When the dose is reduced, the nervous system needs time to adjust to the new level and settle. The hold is that time.

Holds are a planned part of a taper, not a failure of one. They let a person tell temporary adjustment symptoms from persisting withdrawal, and they give the body a chance to catch up before the next cut. The Ashton Manual’s withdrawal schedules are built from small reductions separated by intervals, and Professor C. Heather Ashton wrote of them that “schedules such as these have worked on real people, but you may need to adapt them for your own needs”. The Manual says that “the precise rate of withdrawal is an individual matter” and that you “must proceed at the pace that is comfortable for you”; its schedules allow two weeks per stage “if preferred”, and it says you “can stand still at a certain stage in your withdrawal for a few weeks” when you need to. How long a hold should last depends on the specific benzodiazepine, the dose, the duration of use, the individual, and the symptoms present.

Factors to Consider When Determining Holding Periods

The length of a hold is decided by the person’s response, not by the calendar. Each body reacts differently to a dose change, and some people need longer at each level than others. History with the medication matters: how long it has been taken, how high the dose has been, and what happened during any earlier attempts to reduce it. Age, other medical conditions, and mental health all affect how well a reduction is tolerated. Taking these factors into account, with a prescriber who knows the history, is how a taper is fitted to the person.

Monitoring Progress and Adjusting Holding Periods

Keeping track of how you feel during a hold is what makes it useful. A short daily note on physical sensations, anxiety, sleep, and functioning shows whether symptoms are settling, holding steady, or getting worse. If a hold is going badly, the sensible response is to extend it before reducing again. If you feel stable, the next cut can be planned. If a long hold brings no improvement, or symptoms keep escalating, a hold on its own may not be enough; that situation is discussed in when and how to updose for severe symptoms. Decisions like these are best made with a physician who understands benzodiazepine tapering. Medically supervised tapering is preferred to tapering without a physician.

How to Implement Holding Periods During Your Benzodiazepine Taper

A benzodiazepine taper needs planned holds so the nervous system has time to stabilize between reductions. The steps below describe how holds are built into a taper; the specific amounts and timing are for you and your prescriber to decide.

  • Establish a stable baseline before the first cut. Before any reduction, aim for a period of relatively stable symptoms, often one to two weeks. Note your current symptom levels, sleep quality, and daily functioning so you have a reference point for what changes after the cut.
  • Make the reduction and start tracking symptoms right away. After reducing by the amount agreed with your prescriber (the Maudsley Deprescribing Guidelines and hyperbolic schedules commonly use cuts in the range of 5 to 10 percent of the current dose), begin a daily log of physical sensations, anxiety, sleep, and thinking. This record is what tells you when you have stabilized.
  • Expect an initial adjustment period. In practice, most people feel heightened symptoms in the first week or two after a cut as the body adjusts to the lower level. Increased anxiety, disturbed sleep, or physical discomfort in this window is expected and does not by itself mean the dose needs to change.
  • Watch for the stabilization window. Stabilization means symptoms have returned to near your baseline or have clearly eased from their post-cut peak. For many people this happens somewhere between two and six weeks after a reduction, but the range is wide and depends on taper speed, duration of use, and the individual. These are illustrative ranges, not a schedule to follow.
  • Hold at the current dose until symptoms plateau. Once you notice improvement, keep holding until symptoms have been steady for a week or two. Cutting again before you have stabilized risks symptoms piling up from one reduction to the next.
  • Adjust holds to your own pattern. If you needed four weeks to settle after one cut, plan on a similar or longer hold after the next. At lower doses, the same percentage reduction is a larger change for an adapted nervous system, so holds tend to lengthen toward the end of a taper. This is the reason cuts should get smaller as the dose falls, explained in hyperbolic tapering. The Maudsley Deprescribing Guidelines, written after the Ashton Manual, make the same point about cuts shrinking as the dose falls: reductions become smaller and slower as the dose approaches zero.
  • Keep a record of your holds. Note how long each hold lasted and what stabilization felt like for you. That record helps predict what you will need later in the taper and helps you tell ordinary adjustment from symptoms that are escalating.

Frequently Asked Questions About Holding Periods

How long should I hold between benzodiazepine dose reductions?

There is no fixed answer. In clinical experience many people need somewhere between two and six weeks at each dose level to stabilize, and some, particularly after long-term use or higher doses, need considerably longer. The signal to move on is symptom stabilization rather than a date on a calendar: you should feel relatively stable and able to function before the next reduction.

What does stabilization actually feel like during a benzo taper?

Stabilization does not mean feeling completely normal or symptom-free. It means your symptoms have leveled off at a manageable intensity and are no longer getting worse. You may still have some anxiety, sleep difficulty, or physical sensations, but they are roughly consistent from day to day rather than escalating. Many people describe it as a “new normal” in which they can manage daily activities reasonably well.

Can I make my next cut sooner if I am feeling better quickly?

It is tempting to speed up when you feel well, but going too fast is one of the most common reasons tapers run into trouble. Even if you feel stable after a week, the nervous system is still adjusting. Cutting too rapidly can produce cumulative destabilization, with symptoms compounding from one reduction to the next until you are forced to slow down, hold longer, or go back up in dose. Patience during holds protects the rest of the taper.

What if my symptoms are not improving after six to eight weeks at the same dose?

If you have held for six to eight weeks without meaningful improvement, several things could be going on. The previous cut may have been too large, the overall pace may be too fast for you, or another health problem may be complicating the picture. This is a situation to review with a physician who understands benzodiazepine tapering, who can help you decide whether to keep holding, make a smaller next cut, or go back up slightly to restabilize.

Do I need longer holding periods as I get to lower doses?

Usually, yes. The same percentage reduction is a larger relative change to the GABA-A receptors at a lower dose, and the nervous system becomes more sensitive as it adjusts to functioning with less benzodiazepine. This varies from person to person, but planning for longer holds in the later stages of a taper, sometimes many weeks between cuts, is realistic and protective.

Understanding Benzodiazepine Dependence and Withdrawal

Benzodiazepine dependence develops when the brain adapts to the presence of the medication, a process called neuroadaptation. Benzodiazepines enhance the effect of GABA, the brain’s main inhibitory neurotransmitter. With regular use, sometimes within a few weeks, the brain reduces the number of its GABA-A receptors and adjusts its chemistry to maintain balance in the presence of the drug. This physical adaptation is not addiction, and it occurs in people taking a benzodiazepine exactly as prescribed for a legitimate medical condition.

When intake is reduced or stopped, the adapted nervous system has to readjust. That readjustment produces withdrawal symptoms, which can include anxiety, insomnia, sensory sensitivity, muscle tension, difficulty concentrating, and a range of physical symptoms. Their severity and duration vary with the specific benzodiazepine, duration of use, dose, individual physiology, and taper speed. With a gradual taper, withdrawal is uncomfortable rather than dangerous for most people; abrupt cessation, by contrast, can cause seizures. Call emergency services for a seizure or any other medical emergency.

Benzodiazepine withdrawal is often prolonged compared with withdrawal from many other substances. Acute symptoms after a reduction usually peak within the first two weeks, but the nervous system’s return to normal receptor density and function continues for months, and in some people much longer, after the last dose. Understanding this is what makes the slow, steady approach easier to accept: each hold is time the nervous system uses. The Ashton Manual Guide taper calculator shows how tapers of this shape are planned, with holds built in; it is an educational planning tool, and the plan itself belongs to you and your prescriber.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Picture of Mark Leeds, D.O.

Mark Leeds, D.O.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist. He graduated from Des Moines University College of Osteopathic Medicine in 1996 and completed his family medicine residency at Westchester General Hospital in 1999. Dr. Leeds specializes in benzodiazepine and psychiatric medication dependence, with a clinical focus on helping patients taper these medications safely. He also serves on the medical advisory board of the Benzodiazepine Information Coalition.